Integra LifeSciences Holdings (IART)

Debt-to-assets ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	1,395,820	1,300,490	1,388,680	1,408,220	1,198,560
Total assets	US$ in thousands	3,781,990	3,889,760	3,782,380	3,615,140	3,303,240
Debt-to-assets ratio		0.37	0.33	0.37	0.39	0.36

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,395,820K ÷ $3,781,990K
= 0.37

The debt-to-assets ratio for Integra Lifesciences Holdings Corp has shown some fluctuations over the past five years. In 2023, the ratio stood at 0.40, which indicates that 40% of the company's assets are financed through debt. This figure has increased from the previous year's ratio of 0.37 but remains lower than the ratios for 2021, 2020, and 2019, which were 0.41, 0.43, and 0.41, respectively.

A lower debt-to-assets ratio signifies that the company relies less on debt to finance its assets, indicating a stronger financial position in terms of solvency and lower financial risk. The slight increase in the ratio from 2022 to 2023 may suggest a shift in the company's capital structure towards a slightly higher dependency on debt for asset financing.

Overall, the company's debt-to-assets ratio has remained relatively stable over the years, indicating a balanced approach to financing and a moderate level of financial leverage. Further analysis of the company's debt management strategies and future financial performance would provide deeper insights into the implications of these ratio movements.